Taniguchi Y, Tonai-Kachi H, Shinjo K (2006). „Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35”. FEBS Lett. 580 (21): 5003—8. PMID16934253. doi:10.1016/j.febslet.2006.08.015.
Shrimpton AE, Braddock BR, Thomson LL, Stein CK, Hoo JJ (2004). „Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype”. Clin. Genet. 66 (6): 537—44. PMID15521982. doi:10.1111/j.1399-0004.2004.00363.x.
Taniguchi Y, Tonai-Kachi H, Shinjo K (2006). „Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35”. FEBS Lett. 580 (21): 5003—8. PMID16934253. doi:10.1016/j.febslet.2006.08.015.
Shrimpton AE, Braddock BR, Thomson LL, Stein CK, Hoo JJ (2004). „Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype”. Clin. Genet. 66 (6): 537—44. PMID15521982. doi:10.1111/j.1399-0004.2004.00363.x.